Assessment of Effectiveness of Neuromuscular Training in Treatment of Lumbar Spine in Football Players

NCT04134741 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-10-22

No results posted yet for this study

Summary

The project aims to assess the effectiveness of neuromuscular training according to the concept of Kinetic Control (KC) in prevention and treatment of lumbar spine and knee pain and in reduction of risk of injury in female football players.

The study was designed as single-blind Randomized Controlled Trial (RCT) and conducted on a group of 18 female football players from University Club of the Academic Sports Association of Pope John Paul II State School of Higher Education in Biała Podlaska. Participants were randomly divided into two 9-person groups: A - used standard training and neuromuscular training (Kinetic Control) and B - used only standard training.

Main hypothesis:

The application of neuromuscular therapy (KC) reduces the risk of injuries and pain of the lumbar spine and the knee and improves the static and dynamic balance.

Research questions:

1. Will the application of the KC training reduce the risk and frequency of spine and knee injuries in females football players?
2. Will the KC training lead to reduction of the intensity of lumbar spine and knee pain?
3. Will the application of the KC training lead to increase in the torque strength of knee flexors and extensors and improved stability of the knee?
4. Will the application of the neuromuscular training (KC) lead to reduction of the disability level and improved functional level?

Conditions

  • Injury Leg
  • Back Pain
  • Sport Injury
  • Training Group, Sensitivity
  • Prevention

Interventions

OTHER

Kinetic Control

The Kinetic Control training included a functional examination of motor disorders and individual training. The KC training included active exercises, active exercises with torso muscle resistance and exercises involving lower limbs. The duration of one training was 20-30 minutes.

Sponsors & Collaborators

  • John Paul II University in Biała Podlaska

    lead OTHER

Principal Investigators

  • Kamil Zaworski, PhD · John Paul II University in Biała Podlaska

  • Anna Kręgiel, PhD · John Paul II University in Biała Podlaska

  • Krystyna Gawlik, PhD · John Paul II University in Biała Podlaska

  • Joanna Baj-Korpak, PhD · John Paul II University in Biała Podlaska

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2019-06-16
Completion
2019-06-16

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04134741 on ClinicalTrials.gov